SEMA3B and rheumatoid arthritis: In particular, semaphorin-3B and semaphorin-3F reduce the migratory and invasive capacity of RA FLSs and suppress the expression of MMPs, thus being proposed as therapeutic targets in suppressing the invasive behavior of RA FLSs [81].